Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Intellia Therapeutics, Inc.

NTLA Clue Score53
United States Fiscal year ends December CIK 0001652130 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Fred E Cohen
5 Jan 2026
Director
Buy
150,000
$9.35
$1.40M
William J Chase
20 Aug 2025
Director
Buy
100,000
$10.03
$1.00M
Showing 250 of 298 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 289
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 158
Sales at will 115
Transactions with no price 1
Shares from compensation/vesting 4,470,192
Sales filed before the plan box existed 75
History held since 9 May 2016